The guide explained that its effectiveness extends to protecting pregnant women during and after pregnancy, and provides protection for infants in their first months of life, as well as its role in reducing the severity of the illness when infected, ensuring protection for both the individual and the community.

It clarified that the vaccine is given as an inactivated virus dose via injection in the arm, and can be administered to all individuals starting from six months of age. It emphasized the importance of vaccinating groups at higher risk of severe complications, such as pregnant women at all stages of pregnancy, children up to five years old, the elderly, those with chronic diseases, pilgrims, and healthcare workers.

Although most cases recover within one week without medical intervention, the illness can lead to serious complications requiring hospitalization, especially among high-risk groups such as children under five, the elderly, pregnant women, those with chronic diseases, and healthcare workers.

The incubation period of the virus ranges between two and four days, and it is transmitted through droplets produced by coughing, sneezing, or direct conversation with an infected person. It can also be transmitted indirectly by touching contaminated surfaces or hands and then touching the eyes, nose, or mouth. The most common symptoms include fever, cough, headache, muscle and joint pain, general fatigue, in addition to sore throat and runny nose. Young children may also experience nausea, vomiting, and diarrhea.